Paul Sanders

Paul Sanders

University of Alabama at Birmingham

H-index: 60

North America-United States

About Paul Sanders

Paul Sanders, With an exceptional h-index of 60 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Alabama at Birmingham,

His recent articles reflect a diverse array of research interests and contributions to the field:

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

Efficacy and safety of crisaborole ointment, 2%, in participants aged≥ 45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase …

Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis

42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method

Once-daily crisaborole ointment, 2%, as a long-term maintenance treatment in patients aged≥ 3 months with mild-to-moderate atopic dermatitis: a 52-week clinical study

Endothelial cells overexpressing CXCR1/2 are renoprotective in rats with acute kidney injury

288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial

Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease

Paul Sanders Information

University

Position

___

Citations(all)

11265

Citations(since 2020)

3500

Cited By

9197

hIndex(all)

60

hIndex(since 2020)

30

i10Index(all)

142

i10Index(since 2020)

86

Email

University Profile Page

University of Alabama at Birmingham

Google Scholar

View Google Scholar Profile

Top articles of Paul Sanders

Title

Journal

Author(s)

Publication Date

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

Dermatology and Therapy

Lawrence F Eichenfield

Linda F Stein Gold

Charles Lynde

Lyn Guenther

Shoshana Greenberger

...

2024/3/28

Efficacy and safety of crisaborole ointment, 2%, in participants aged≥ 45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase …

Journal of the American Academy of Dermatology

Jonathan I Silverberg

Robert S Kirsner

David J Margolis

Michael Tharp

Daniela E Myers

...

2024/2/8

Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis

Dermatitis®

Linda F Stein Gold

Wynnis L Tom

Vivian Shi

Paul Sanders

Chuanbo Zang

...

2024/2/1

42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method

Journal of the American Academy of Dermatology

Jonathan I Silverberg

Robert S Kirsner

David Margolis

Michael Tharp

Daniela E Myers

...

2023/9/1

Once-daily crisaborole ointment, 2%, as a long-term maintenance treatment in patients aged≥ 3 months with mild-to-moderate atopic dermatitis: a 52-week clinical study

American Journal of Clinical Dermatology

Lawrence F Eichenfield

Richard G Gower

JinHua Xu

Maryam S Alam

John C Su

...

2023/7

Endothelial cells overexpressing CXCR1/2 are renoprotective in rats with acute kidney injury

American Journal of Physiology-Renal Physiology

Dongqi Xing

Fadi G Hage

Wenguang Feng

Yuanyuan Guo

Suzanne Oparil

...

2023/4/1

288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial

British Journal of Dermatology

Richard Gower

JinHua Xu

Maryam S Alam

John C Su

Daniela E Myers

...

2023/2/7

Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease

Kidney International

Wenguang Feng

Zhengrong Guan

Wei-Zhong Ying

Dongqi Xing

Kai Er Ying

...

2023/10/1

26. Once-Daily Crisaborole as a Long-Term Maintenance Treatment in Patients with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Trial

Journal of Dermatology for Physician Assistants

Richard Gower

JinHua Xu

Maryam S Alam

John C Su

Daniela E Myers

...

2022/10/1

Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B0AT1 (Slc6a19)

American Journal of Physiology-Renal Physiology

Aleix Navarro Garrido

Young Chul Kim

Yuji Oe

Haiyan Zhang

Maria Crespo-Masip

...

2022/10/1

Dietary salt initiates redox signaling between endothelium and vascular smooth muscle through NADPH oxidase 4

Redox Biology

Kai er Ying

Wenguang Feng

Wei-Zhong Ying

Xingsheng Li

Dongqi Xing

...

2022/6/1

Racial differences in XO (xanthine oxidase) and mitochondrial DNA damage-associated molecular patterns in resistant hypertension

Hypertension

Brittany Butts

Jamelle A Brown

Thomas S Denney Jr

Scott Ballinger

Steven G Lloyd

...

2022/4

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Blood

Andrea Angioi

Moritz Binder

Nelson Leung

Frank Bridoux

Camille Cohen

...

2022/11/15

Vehicles for atopic dermatitis therapies: more than just a placebo

Simon G Danby

Zoe D Draelos

Linda F Stein Gold

Amy Cha

Bonnie Vlahos

...

2022/2/17

Cellular antioxidant mechanisms control immunoglobulin light chain-mediated proximal tubule injury

Free Radical Biology and Medicine

Kai er Ying

Wenguang Feng

Wei-Zhong Ying

Paul W Sanders

2021/8/1

UAB-UCSD O’Brien center for acute kidney injury research

Lisa M Curtis

James George

Volker Vallon

Stephen Barnes

Victor Darley-Usmar

...

2021/5/1

The proximal tubule toxicity of immunoglobulin light chains

Christophe Sirac

Vecihi Batuman

Paul W Sanders

2021/5/1

Relationship among treatment, pruritus, investigator’s static global assessment, and quality of life in patients with atopic dermatitis

Dermatology and therapy

Eric L Simpson

Wynnis L Tom

Andrew G Bushmakin

Joseph C Cappelleri

Gil Yosipovitch

...

2021/4

Restoration of afferent arteriolar autoregulatory behavior in ischemia-reperfusion injury in rat kidneys

American Journal of Physiology-Renal Physiology

Wenguang Feng

Ijeoma E Obi

Stephen R Aldous

Samia I Meera

Paul W Sanders

...

2021/3/1

Tempol Improves Renal Autoregulation and Kidney Function Following Ischemia‐Reperfusion Injury in Rats

The FASEB Journal

Zhengrong Guan

Wenguang Feng

Bailey A McEachen

Paul W Sanders

Edward W Inscho

2020/4

See List of Professors in Paul Sanders University(University of Alabama at Birmingham)